FAQ

FRA9E gene

Known as: FRA9E, fragile site, aphidicolin type, common, fra(9)(q32) 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2012
01220032012

Related topics

Related topics

1 relation
FRA10A gene

Related mentions per year

Related mentions per year

1993-2012
1990200020102020
FRA9E gene
FRA10A gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
2′-Deoxyriboguanylurea, the primary breakdown product of 5-aza-2′-deoxyribocytidine, is a mutagen, an epimutagen, an inhibitor of DNA methyltransferases and an inducer of 5-azacytidine-type fragile…
5-Aza-2'-deoxycytidine (5azaC-dR) has been employed as an inhibitor of DNA methylation, a chemotherapeutic agent, a clastogen, a… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2008
Review
2008
Human chromosome fragility.
Fragile sites are heritable specific chromosome loci that exhibit an increased frequency of gaps, poor staining, constrictions or… (More)
  • table 1
  • table 2
Is this relevant?
2003
2003
Characterization of the common fragile site FRA9E and its potential role in ovarian cancer
Common fragile sites (CFSs) are regions of profound genomic instability that have been hypothesized to play a role in cancer. The… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Review
2003
Review
2003
Fragile sites and bladder cancer.
Continued reports of associations between environmentally induced chromosomal fragile sites and cancer prompted us to undertake a… (More)
Is this relevant?